Model Uncertainty And Bayesian Model Averaged Benchmark Dose Estimation For Continuous Data
On this page:
The benchmark dose (BMD) approach has gained acceptance as a valuable risk assessment tool, but risk assessors still face significant challenges associated with selecting an appropriate BMD/BMDL estimate from the results of a set of acceptable dose-response models. Current approaches might not fully take into account model uncertainty. Hence, an opportunity exists to more fully inform health risk assessors.